Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium
- PMID: 26320942
- PMCID: PMC4553260
- DOI: 10.3402/jev.v4.27575
Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium
Abstract
The NIH Extracellular RNA Communication Program's initiative on clinical utility of extracellular RNAs and therapeutic agents and developing scalable technologies is reviewed here. Background information and details of the projects are presented. The work has focused on modulation of target cell fate by extracellular vesicles (EVs) and RNA. Work on plant-derived vesicles is of intense interest, and non-mammalian sources of vesicles may represent a very promising source for different therapeutic approaches. Retro-viral-like particles are intriguing. Clearly, EVs share pathways with the assembly machinery of several other viruses, including human endogenous retrovirals (HERVs), and this convergence may explain the observation of viral-like particles containing viral proteins and nucleic acid in EVs. Dramatic effect on regeneration of damaged bone marrow, renal, pulmonary and cardiovascular tissue is demonstrated and discussed. These studies show restoration of injured cell function and the importance of heterogeneity of different vesicle populations. The potential for neural regeneration is explored, and the capacity to promote and reverse neoplasia by EV exposure is described. The tremendous clinical potential of EVs underlies many of these projects, and the importance of regulatory issues and the necessity of general manufacturing production (GMP) studies for eventual clinical trials are emphasized. Clinical trials are already being pursued and should expand dramatically in the near future.
Keywords: cancer; cell fate change; extracellular vesicles; functional effects; pulmonary heart disease; renal.
Figures
References
-
- Gould SJ, Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. 2013;2 20389, doi: http://dx.doi.org/10.3402/jev.v2i0.20389. - DOI - PMC - PubMed
-
- Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular ‘debris’. Semin Immunopathol. 2011;33:455–67. - PubMed
-
- Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol. 2012;22:125–32. - PubMed
Grants and funding
- R01 HL122547/HL/NHLBI NIH HHS/United States
- P50 CA095103/CA/NCI NIH HHS/United States
- UH2 TR000875/TR/NCATS NIH HHS/United States
- P30 DK058404/DK/NIDDK NIH HHS/United States
- UH2 TR000928/TR/NCATS NIH HHS/United States
- U19 CA179514/CA/NCI NIH HHS/United States
- UH3 TR000880/TR/NCATS NIH HHS/United States
- UH3 TR000918/TR/NCATS NIH HHS/United States
- UH2 TR000880/TR/NCATS NIH HHS/United States
- U19 CA179563/CA/NCI NIH HHS/United States
- UH3 TR000901/TR/NCATS NIH HHS/United States
- UH3 TR000928/TR/NCATS NIH HHS/United States
- R01 CA163563/CA/NCI NIH HHS/United States
- UH2 TR000901/TR/NCATS NIH HHS/United States
- T32 HL116249/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
